Nationally recognized as the third-largest biopharma hub in the country, and home to thriving industry clusters including technology, defense, and satellite and advanced communications, Montgomery County continues to attract global brands, generate high-quality and high-paying jobs, and drive economic growth.

Recent investments from global industry leaders highlight this continued momentum.

This past March, Samsung Biologics had its official ribbon cutting in Rockville. The Korean contract development and manufacturing leader expanded into the U.S. market through its acquisition of the former Human Genome Sciences facility in Rockville. The acquisition will retain more than 500 jobs and marks Samsung Biologics’ first U.S.-based manufacturing site, further cementing Montgomery County’s position as a premier destination for life sciences companies of all sizes. “During our international trade mission last year, we met with the Samsung Biologics team in Seoul to discuss the economic momentum in Maryland. Today’s ribbon cutting is the realization of that meeting and our state’s momentum,” said Maryland Governor Wes Moore. “South Korea’s largest biotech company is opening its first U.S. manufacturing facility here in Maryland. In the state of Maryland, we are delivering for our people and not playing for second.”

Last October, biopharmaceutical giant AstraZeneca, headquartered in Gaithersburg since 2013, announced that it will build another state-of-the art facility, also in Gaithersburg. This new facility, which follows the opening of the company’s $300 million cell therapy manufacturing facility opened in Rockville last spring, will create 100 new jobs and continue to expand the company’s R&D footprint in the County. (more…)